1. SAT0673 Risk age and relative risk of cvd in inflammatory joint diseases. (15th June 2017) Authors: Wibetoe, G; Ikdahl, E; Rollefstad, S; Olsen, I; Bergsmark, K; Kvien, T; Salberg, A; Soldal, D; Bakland, G; Lexberg, Å; Fevang, BT; Gulseth, HC; Haugeberg, G; Semb, AG Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1029 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Short-term treatment with a gonadotropin-releasing hormone antagonist, cetrorelix, in rheumatoid arthritis (AGRA): a randomized, double-blind, placebo-controlled study. (January 2014) Authors: Kåss, AS; Førre, ØT; Fagerland, MW; Gulseth, HC; Torjesen, PA; Hollan, I Journal: Scandinavian journal of rheumatology Issue: Volume 43:Number 1(2014) Page Start: 22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Short-term treatment with a gonadotropin-releasing hormone antagonist, cetrorelix, in rheumatoid arthritis (AGRA): a randomized, double-blind, placebo-controlled study. (January 2014) Authors: Kåss, AS; Førre, ØT; Fagerland, MW; Gulseth, HC; Torjesen, PA; Hollan, I Journal: Scandinavian journal of rheumatology Issue: Volume 43:Number 1(2014) Page Start: 22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗